source
- FDA grants approval to Ultragenyx's Genglycos gene therapy for ultra-rare glycogen storage disorderUltragenyx announced that the U.S. Food and Drug Administration has approved its gene therapy called Genglycos. The therapy targets an ultra-rare glycogen storage disorder that can lead to severe…
- WuXi Bio to offload chromatography unit; Cabaletta names another CDMO partnerPlus, SK pharmteco’s Ireland expansions. 🇨🇳 WuXi Bio to divest Shanghai subsidiary: The company is selling its 51.1% equity stake in chromatography resin supplier Bestchrom to an unnamed third pa…Endpoints · 1h ago↗ source